Next-Generation Wearables: Applications and Opportunities for Pharma
How–and where–can pharma leverage value from next-generation wearable technology?
Powerful second-generation smart wearable devices such as hearables/earables, head-mounted displays, clothing, implantables and patches will provide greater diagnosis and disease management insights. So how does pharma benefit? How can wearables and digital biomarkers demonstrate the clinical value of a new medicine? How might they improve clinical trials and drug delivery? What are the data, technology and regulatory challenges?
CompaniesRoche, Sanofi, Google, Fitbit, Proteus Digital Health, Apple, Verily Life Sciences, Microsoft, J&J, Abbott, Empatica, Garmin, Hexoskin, Nike, Samsung, Komodo Health, Magic Leap, HTC, InWith Corporation, XRHealth, HP, Movano, Oura Health, Otsuka Pharmaceutical, RapidSOS, Jabra, Joule, Kinexon, Koneska, Kokoon Technology, Lenovo, Lets Innovate, Lexie Hearing, Lifesum, LogicInk, McLear, Neopenda, Nuheara, Olive Union, Playermaker, RealWear, Respiree, Sibel Health, Sennheiser, SiFive, SoundWorld Solutions, STAT Health, TNO, Xenoma, Xiaomi, Under Armour, Vuzix, Zhor-Tech, Innovega